DAVID A SCHEINBERG
CIK 1250316 · last filed 2026-01-09
DAVID A SCHEINBERG is a corporate insider who has filed 38 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for SLS, was dated Jan 9, 2026. Across all open-market trades the lifetime net is −$1.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $572.2K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$572.2K
4
38
-$1.18M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SLS | Director | 73,082 | $7.83 | $572.2K | $0 | 11 | 2026-01-09 |
| PROGENICS PHARMACEUTICALS INC (PGNX) Delisted | Director | 56,185 | — | — | -$1.18M | 24 | 2019-07-15 |
| SELLAS Life Sciences Group, Inc. (GALE) Delisted | Director | 9,107 | — | — | $0 | 1 | 2017-12-29 |
| CONTRAFECT Corp (CFRX.Z) Delisted | Director | — | — | — | $0 | 2 | 2015-05-06 |
Recent Filings
38 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-09 | SLS | Grant (A) | +50,000 | $0 | EDGAR |
| 2025-01-14 | SLS | Grant (A) | +12,500 | $0 | EDGAR |
| 2024-01-25 | SLS | Grant (A) | +6,000 | $0 | EDGAR |
| 2023-02-03 | SLS | Grant (A) | +2,500 | $0 | EDGAR |
| 2022-02-01 | SLS | Grant (A) | +1,900 | $0 | EDGAR |
| 2021-03-08 | SLS | Grant (A) | — | $0 | EDGAR |
| 2020-03-16 | SLS | Grant (A) | — | $0 | EDGAR |
| 2019-07-15 | PROGENICS PHARMACEUTICALS INC (PGNX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-07-03 | PROGENICS PHARMACEUTICALS INC (PGNX) Delisted | Exer (M) | +10,000 | $53.3K | EDGAR |
| 2019-03-18 | SLS | Grant (A) | — | $0 | EDGAR |